Genetic insights into moderate-to-severe asthma

被引：8
|
作者：
Nadif, Rachel [1 ]
机构：
[1] Hop Paul Brousse, INSERM, U1168, Aging & Chron Dis,Epidemiol & Publ Hlth Approache, F-94807 Villejuif, France
来源：
LANCET RESPIRATORY MEDICINE | 2019年 / 7卷 / 01期
关键词：
D O I：
10.1016/S2213-2600(18)30447-8
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2 / 3
页数：2
相关论文
共 50 条
  • [41] Health care claims analysis to quantify the burden of moderate-to-severe asthma
    Zazzali, James
    Chang, Eunice
    Broder, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [42] Racial and Ethnic Disparities in Biologic Prescriptions for Moderate-to-Severe Persistent Asthma
    Sylvestre, Sebastian
    Kaminsky, Lauren
    Al-Shaikhly, Taha
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB151 - AB151
  • [43] Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial
    Holgate, S. T.
    Noonan, M.
    Chanez, P.
    Busse, W.
    Dupont, L.
    Pavord, I.
    Hakulinen, A.
    Paolozzi, L.
    Wajdula, J.
    Zang, C.
    Nelson, H.
    Raible, D.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (06) : 1352 - 1359
  • [44] Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma
    Papi, Alberto
    Castro, Mario
    Corren, Jonathan
    Pavord, Ian D.
    Tohda, Yuji
    Altincatal, Arman
    Pandit-Abid, Nami
    Laws, Elizabeth
    Akinlade, Bolanle
    Mannent, Leda P.
    Gall, Rebecca
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    Lederer, David J.
    Hardin, Megan
    RESPIRATORY MEDICINE, 2024, 224
  • [45] Clinical Response Predictive Model for Omalizumab in Moderate-to-Severe Asthma Patients
    Qian, Ruiqi
    Yang, Lingyi
    Shen, Xurui
    Chen, Cheng
    Huang, Jianan
    Zhang, Xiuqin
    Fu, Cuiping
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2024, 2024
  • [46] Effectiveness and Safety Studies of Omalizumab in Children and Adolescents With Moderate-To-Severe Asthma
    Cheng, Lu
    Yang, Tianrui
    Ma, Xiang
    Han, Yuling
    Wang, Yongtai
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (02) : 370 - 382
  • [47] Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization
    Corren, Jonathan
    Hanania, Nicola A.
    Busse, William W.
    Sher, Lawrence D.
    Altincatal, Arman
    Hardin, Megan
    Mannent, Leda P.
    Amin, Nikhil
    Lederer, David J.
    Soler, Xavier
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (10): : 1020 - 1030
  • [48] Characterizing patients with moderate-to-severe asthma with preserved small airway function
    Chan, Rory
    Lipworth, Brian
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (01) : 93 - 95
  • [49] Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine
    Mustafa, S. Shahzad
    Patrawala, Sara
    Khurana, Sandhya
    CURRENT OPINION IN PULMONARY MEDICINE, 2022, 28 (03) : 266 - 273
  • [50] Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab
    Long, Aidan
    Rahmaoui, Abdelkader
    Rothman, Kenneth J.
    Guinan, Eva
    Eisner, Mark
    Bradley, Mary S.
    Iribarren, Carlos
    Chen, Hubert
    Carrigan, Gillis
    Rosen, Karin
    Szefler, Stanley J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (03) : 560 - +
12345